Last reviewed · How we verify
CMND-100
At a glance
| Generic name | CMND-100 |
|---|---|
| Also known as | MEAI |
| Sponsor | Clearmind Medicine Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |